These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15161615)

  • 1. Montelukast in respiratory syncytial virus postbronchiolitis.
    López-Andreu JA; Cortell-Aznar I; Ruiz-García V
    Am J Respir Crit Care Med; 2004 Jun; 169(11):1255; author reply 1255-6. PubMed ID: 15161615
    [No Abstract]   [Full Text] [Related]  

  • 2. Montelukast for respiratory syncytial virus bronchiolitis: significant effect or provocative findings?
    Szefler SJ; Simoes EA
    Am J Respir Crit Care Med; 2003 Feb; 167(3):290-1. PubMed ID: 12554617
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis.
    Bisgaard H;
    Am J Respir Crit Care Med; 2003 Feb; 167(3):379-83. PubMed ID: 12406832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Leukotriene and respiratory syncytial virus].
    Zhang WX; Li CC
    Zhonghua Er Ke Za Zhi; 2013 Feb; 51(2):109-10. PubMed ID: 23527973
    [No Abstract]   [Full Text] [Related]  

  • 5. Montelukast in RSV-bronchiolitis.
    Bisgaard H
    Am J Respir Crit Care Med; 2004 Feb; 169(4):542-3. PubMed ID: 14766663
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children.
    Bisgaard H; Flores-Nunez A; Goh A; Azimi P; Halkas A; Malice MP; Marchal JL; Dass SB; Reiss TF; Knorr BA
    Am J Respir Crit Care Med; 2008 Oct; 178(8):854-60. PubMed ID: 18583576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of montelukast's efficacy for preventing post-bronchiolitis wheezing.
    Peng WS; Chen X; Yang XY; Liu EM
    Pediatr Allergy Immunol; 2014 Mar; 25(2):143-50. PubMed ID: 24118637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of interventions during acute respiratory syncytial virus bronchiolitis on subsequent long term respiratory morbidity.
    Khoshoo V; Ross G; Edell D
    Pediatr Infect Dis J; 2002 May; 21(5):468-72. PubMed ID: 12150194
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of montelukast in the treatment of early childhood wheezing from clinical experience with three cases.
    Ng DK; Law AK; Chau KW; Chan HK
    Respirology; 2000 Dec; 5(4):389-92. PubMed ID: 11192552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of respiratory syncytial virus-induced bronchiolitis co-infection with Mycoplasma pneumoniae and add-on therapy with montelukast.
    Wu SH; Chen XQ; Kong X; Yin PL; Dong L; Liao PY; Wu JM
    World J Pediatr; 2016 Feb; 12(1):88-95. PubMed ID: 25846070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Montelukast does not prevent reactive airway disease in young children hospitalized for RSV bronchiolitis.
    Proesmans M; Sauer K; Govaere E; Raes M; De Bilderling G; De Boeck K
    Acta Paediatr; 2009 Nov; 98(11):1830-4. PubMed ID: 19659463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribavirin and cysteinyl leukotriene-1 receptor blockade as treatment for severe bronchiolitis.
    Bonville CA; Rosenberg HF; Domachowske JB
    Antiviral Res; 2006 Feb; 69(2):53-9. PubMed ID: 16337014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized intervention of montelukast for post-bronchiolitis: effect on eosinophil degranulation.
    Kim CK; Choi J; Kim HB; Callaway Z; Shin BM; Kim JT; Fujisawa T; Koh YY
    J Pediatr; 2010 May; 156(5):749-54. PubMed ID: 20171653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Question 2: Is there a role for Montelukast in the management of viral-induced wheeze in preschool children?
    Burman A
    Arch Dis Child; 2018 May; 103(5):519-520. PubMed ID: 29618481
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful drug treatment of immune reconstitution disease with the leukotriene receptor antagonist, montelukast: a clue to pathogenesis?
    Lipman MC; Carding SK
    AIDS; 2007 Jan; 21(3):383-4. PubMed ID: 17255752
    [No Abstract]   [Full Text] [Related]  

  • 16. Montelukast in childhood asthma.
    Mehta PN
    Indian Pediatr; 2000 Nov; 37(11):1201-9. PubMed ID: 11086302
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of long-term treatment with montelukast in mild cystic fibrosis (long term treatment with montelukast in cystic fibrosis).
    Schmitt-Grohé S; Eickmeier O; Naujoks C; Schubert R; Lentze MJ; Zielen S; Rietschel E
    Respir Med; 2007 Mar; 101(3):684. PubMed ID: 17187974
    [No Abstract]   [Full Text] [Related]  

  • 18. Montelukast can reduce the severity and extent of atopic dermatitis.
    Holme H; Winckworth LC
    J Paediatr Child Health; 2013 May; 49(5):412-5. PubMed ID: 23647765
    [No Abstract]   [Full Text] [Related]  

  • 19. [Successful and effective: Montelukast in clinical practice].
    Internist (Berl); 1999 Dec; 40(12 Suppl Montelukas):1-4. PubMed ID: 10635479
    [No Abstract]   [Full Text] [Related]  

  • 20. Is montelukast indicated for treatment of chronic rhinosinusitis with polyposis?
    Smith TL; Sautter NB
    Laryngoscope; 2014 Aug; 124(8):1735-6. PubMed ID: 24338615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.